Severe Immune-Related Pneumonitis With PD-1 Inhibitor After Progression on Previous PD-L1 Inhibitor in Small Cell Lung Cancer: A Case Report and Review of the Literature-Reference-Cited by-同舟云学术

Severe Immune-Related Pneumonitis With PD-1 Inhibitor After Progression on Previous PD-L1 Inhibitor in Small Cell Lung Cancer: A Case Report and Review of the Literature

Published:2019-12-18 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Liang Xiuju,Guan Yaping,Zhang Bicheng,Liang Jing,Wang Baocheng,Li Yan,Wang Jun

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference27 articles.

1. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion;Schreiber;Science,2011

2. Immune checkpoint blockade in cancer therapy;Postow;J Clin Oncol,2015

3. Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies;Naidoo;Ann Oncol,2016

4. Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis;Chuzi;Cancer Manag Res,2017

5. Anti-PD-1 inhibitor-related pneumonitis in non-small cell lung cancer;Nishino;Cancer Immunol Res,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uncommon Adverse Events of Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Systematic Review of Case Reports;Cancers;2024-05-16

2. Взаимозаменяемость анти-PD1 препаратов как инструмент реагирования на сложные условия финансирования;Malignant tumours;2023-11-22

3. Eosinophil as a biomarker for diagnosis, prediction, and prognosis evaluation of severe checkpoint inhibitor pneumonitis;Frontiers in Oncology;2022-08-12

4. Excellent Response to Atezolizumab After Clinically Defined Hyperprogression Upon Previous Treatment With Pembrolizumab in Metastatic Triple-Negative Breast Cancer: A Case Report and Review of the Literature;Frontiers in Immunology;2021-05-31

5. Piperlongumine Analogs Promote A549 Cell Apoptosis through Enhancing ROS Generation;Molecules;2021-05-28